394 related articles for article (PubMed ID: 30002199)
1. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
Redondo MJ; Geyer S; Steck AK; Sharp S; Wentworth JM; Weedon MN; Antinozzi P; Sosenko J; Atkinson M; Pugliese A; Oram RA;
Diabetes Care; 2018 Sep; 41(9):1887-1894. PubMed ID: 30002199
[TBL] [Abstract][Full Text] [Related]
2. Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk.
Tosur M; Geyer SM; Rodriguez H; Libman I; Baidal DA; Redondo MJ;
Diabetologia; 2018 Sep; 61(9):2043-2053. PubMed ID: 29931415
[TBL] [Abstract][Full Text] [Related]
3. Accelerated Progression to Type 1 Diabetes in the Presence of
Balke EM; Balti EV; Van der Auwera B; Weets I; Costa O; Demeester S; Abrams P; Casteels K; Coeckelberghs M; Tenoutasse S; Keymeulen B; Pipeleers DG; Gorus FK;
Diabetes Care; 2018 May; 41(5):1076-1083. PubMed ID: 29545461
[TBL] [Abstract][Full Text] [Related]
4. Transcription Factor 7-Like 2 (
Redondo MJ; Steck AK; Sosenko J; Anderson M; Antinozzi P; Michels A; Wentworth JM; Atkinson MA; Pugliese A; Geyer S;
Diabetes Care; 2018 Dec; 41(12):2480-2486. PubMed ID: 30275285
[TBL] [Abstract][Full Text] [Related]
5. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance.
Redondo MJ; Sosenko J; Libman I; McVean JJF; Tosur M; Atkinson MA; Becker D; Geyer S
J Clin Endocrinol Metab; 2020 May; 105(5):1629-40. PubMed ID: 31867614
[TBL] [Abstract][Full Text] [Related]
6. Excess BMI Accelerates Islet Autoimmunity in Older Children and Adolescents.
Ferrara-Cook C; Geyer SM; Evans-Molina C; Libman IM; Becker DJ; Gitelman SE; Redondo MJ;
Diabetes Care; 2020 Mar; 43(3):580-587. PubMed ID: 31937610
[TBL] [Abstract][Full Text] [Related]
7. Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study.
Beyerlein A; Bonifacio E; Vehik K; Hippich M; Winkler C; Frohnert BI; Steck AK; Hagopian WA; Krischer JP; Lernmark Å; Rewers MJ; She JX; Toppari J; Akolkar B; Rich SS; Ziegler AG;
J Med Genet; 2019 Sep; 56(9):602-605. PubMed ID: 30287597
[TBL] [Abstract][Full Text] [Related]
8. Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report.
Krischer JP; Liu X; Vehik K; Akolkar B; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Lernmark Å;
Diabetes Care; 2019 Jun; 42(6):1051-1060. PubMed ID: 30967432
[TBL] [Abstract][Full Text] [Related]
9. Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children.
Jacobsen LM; Larsson HE; Tamura RN; Vehik K; Clasen J; Sosenko J; Hagopian WA; She JX; Steck AK; Rewers M; Simell O; Toppari J; Veijola R; Ziegler AG; Krischer JP; Akolkar B; Haller MJ;
Pediatr Diabetes; 2019 May; 20(3):263-270. PubMed ID: 30628751
[TBL] [Abstract][Full Text] [Related]
10. A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.
Kozhakhmetova A; Wyatt RC; Caygill C; Williams C; Long AE; Chandler K; Aitken RJ; Wenzlau JM; Davidson HW; Gillespie KM; Williams AJK
Clin Exp Immunol; 2018 Jun; 192(3):251-258. PubMed ID: 29431870
[TBL] [Abstract][Full Text] [Related]
11. Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.
Maziarz M; Hagopian W; Palmer JP; Sanjeevi CB; Kockum I; Breslow N; Lernmark Å; ; ;
Genes Immun; 2015 Dec; 16(8):541-51. PubMed ID: 26513234
[TBL] [Abstract][Full Text] [Related]
12. Evidence of stage- and age-related heterogeneity of non-HLA SNPs and risk of islet autoimmunity and type 1 diabetes: the diabetes autoimmunity study in the young.
Frederiksen BN; Steck AK; Kroehl M; Lamb MM; Wong R; Rewers M; Norris JM
Clin Dev Immunol; 2013; 2013():417657. PubMed ID: 24367383
[TBL] [Abstract][Full Text] [Related]
13. IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity.
Walter M; Albert E; Conrad M; Keller E; Hummel M; Ferber K; Barratt BJ; Todd JA; Ziegler AG; Bonifacio E
Diabetologia; 2003 May; 46(5):712-20. PubMed ID: 12750767
[TBL] [Abstract][Full Text] [Related]
14. Age at Seroconversion, HLA Genotype, and Specificity of Autoantibodies in Progression of Islet Autoimmunity in Childhood.
Bauer W; Veijola R; Lempainen J; Kiviniemi M; Härkönen T; Toppari J; Knip M; Gyenesei A; Ilonen J
J Clin Endocrinol Metab; 2019 Oct; 104(10):4521-4530. PubMed ID: 31120497
[TBL] [Abstract][Full Text] [Related]
15. The Influence of Type 1 Diabetes Genetic Susceptibility Regions, Age, Sex, and Family History on the Progression From Multiple Autoantibodies to Type 1 Diabetes: A TEDDY Study Report.
Krischer JP; Liu X; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
Diabetes; 2017 Dec; 66(12):3122-3129. PubMed ID: 28903990
[TBL] [Abstract][Full Text] [Related]
16. Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes?
Steck AK; Xu P; Geyer S; Redondo MJ; Antinozzi P; Wentworth JM; Sosenko J; Onengut-Gumuscu S; Chen WM; Rich SS; Pugliese A;
J Clin Endocrinol Metab; 2017 Aug; 102(8):2873-2880. PubMed ID: 28520980
[TBL] [Abstract][Full Text] [Related]
17. Genetic prediction of autoimmunity: initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes.
Aly TA; Ide A; Humphrey K; Barker JM; Steck A; Erlich HA; Yu L; Miao D; Redondo MJ; McFann K; Roberts CM; Babu SR; Norris JM; Eisenbarth GS; Rewers MJ
J Autoimmun; 2005; 25 Suppl():40-5. PubMed ID: 16242305
[TBL] [Abstract][Full Text] [Related]
18. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany.
Kordonouri O; Hartmann R; Charpentier N; Knip M; Danne T; Ilonen J
Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):245-9. PubMed ID: 20140847
[TBL] [Abstract][Full Text] [Related]
19. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.
Ziegler AG; Rewers M; Simell O; Simell T; Lempainen J; Steck A; Winkler C; Ilonen J; Veijola R; Knip M; Bonifacio E; Eisenbarth GS
JAMA; 2013 Jun; 309(23):2473-9. PubMed ID: 23780460
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
